131 related articles for article (PubMed ID: 36412321)
1. Chronic myeloid leukemia following radioiodine treatment for papillary carcinoma of thyroid.
Gupta G; Aggarwal M; Juneja R; Seth T
Indian J Cancer; 2022; 59(3):436-437. PubMed ID: 36412321
[No Abstract] [Full Text] [Related]
2. Chronic myeloid leukemia in a woman with papillary carcinoma of the thyroid treated with radioactive iodine.
Alfiar F; Amato D; Lipton JH
Leuk Lymphoma; 1997 Oct; 27(3-4):365-7. PubMed ID: 9402335
[TBL] [Abstract][Full Text] [Related]
3. Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine.
Pavithran K; Doval DC
Am J Clin Oncol; 2005 Apr; 28(2):216. PubMed ID: 15803020
[TBL] [Abstract][Full Text] [Related]
4. Chronic Myeloid Leukemia following Exposure to Radioactive Iodine (I131): A Systematic Review.
Ali Hailan YM; Al-Dubai HN; Yassin MA
Oncology; 2023; 101(6):362-368. PubMed ID: 37231874
[TBL] [Abstract][Full Text] [Related]
5. Acute leukemias after treatment with radioiodine for thyroid cancer.
Roldán Schilling V; Fernández Abellán P; Domínguez Escribano JR; Rivas González C; Mut Barberá E; Calatayud Cendra R
Haematologica; 1998 Aug; 83(8):767-8. PubMed ID: 9793274
[TBL] [Abstract][Full Text] [Related]
6. A case of chronic myelogenous leukemia following I131 therapy for metastatic thyroid carcinoma.
Torng JK; Chen YC; Liu CH; Chen FW
Taiwan Yi Xue Hui Za Zhi; 1984 Jul; 83(7):730-5. PubMed ID: 6594437
[No Abstract] [Full Text] [Related]
7. [Radioiodine in the treatment of generalized papillary and follicular thyroid carcinoma].
Mäenpää H
Duodecim; 2014; 130(6):573-9. PubMed ID: 24724456
[TBL] [Abstract][Full Text] [Related]
8. Mucoepidermoid carcinoma post-radioactive iodine treatment of papillary thyroid carcinoma: unique presentation and putative etiologic association.
Saluja K; Butler RT; Pytynia KB; Zhao B; Karni RJ; Weber RS; El-Naggar AK
Hum Pathol; 2017 Oct; 68():189-192. PubMed ID: 28499545
[TBL] [Abstract][Full Text] [Related]
9. Radioiodine therapy for papillary and follicular thyroid carcinoma.
Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes and prognostic factors of radioiodine ablation therapy for lymph node metastases from papillary thyroid carcinoma.
Wu X; Gu H; Gao Y; Li B; Fan R
Nucl Med Commun; 2018 Jan; 39(1):22-27. PubMed ID: 29135721
[TBL] [Abstract][Full Text] [Related]
11. De-differentiation of papillary thyroid carcinoma into squamous cell carcinoma in an elderly patient: A case report.
Thewjitcharoen Y; Krittiyawong S; Butadej S; Nakasatien S; Polchart S; Junyangdikul P; Kanchanapituk A; Himathongkam T
Medicine (Baltimore); 2020 Apr; 99(16):e19892. PubMed ID: 32312017
[TBL] [Abstract][Full Text] [Related]
12. Gonadal damage due to radioactive iodine (I131) treatment for thyroid carcinoma.
Ahmed SR; Shalet SM
Postgrad Med J; 1985 Apr; 61(714):361-2. PubMed ID: 4022871
[TBL] [Abstract][Full Text] [Related]
13. Peripheral facial nerve palsy after high-dose radioiodine therapy in patients with papillary thyroid carcinoma.
Levenson D; Gulec S; Sonenberg M; Lai E; Goldsmith SJ; Larson SM
Ann Intern Med; 1994 Apr; 120(7):576-8. PubMed ID: 8116996
[No Abstract] [Full Text] [Related]
14. Chronic myeloid leukaemia following 131I treatment for thyroid carcinoma: a report of two cases and review of the literature.
Shimon I; Kneller A; Olchovsky D
Clin Endocrinol (Oxf); 1995 Nov; 43(5):651-4. PubMed ID: 8548952
[TBL] [Abstract][Full Text] [Related]
15. Papillary carcinoma simultaneously involving thyroid, neck lymph-nodes, ovary and bone marrow.
Giovanella L; Suriano S; Ceriani L; Verburg FA
Nuklearmedizin; 2010; 49(6):N66-8. PubMed ID: 21140033
[No Abstract] [Full Text] [Related]
16. Pulmonary fibrosis following radioiodine therapy of pulmonary metastases from differentiated thyroid carcinoma.
Chen L; Shen Y; Luo Q; Yu Y; Lu H; Zhu R
Thyroid; 2010 Mar; 20(3):337-40. PubMed ID: 20187786
[No Abstract] [Full Text] [Related]
17. Should radioactive iodine therapy be administrated in patient of papillary thyroid carcinoma?
Zhao J; Dong J; Sun Q; Wang H; Zhang Z; Zhou X; Liao L
Chin Med J (Engl); 2014; 127(16):3039-40. PubMed ID: 25131255
[No Abstract] [Full Text] [Related]
18. A proposition for the use of radioiodine in WDTC management.
Bourgeois P
J Nucl Med; 2009 Feb; 50(2):328-9; author reply 329-30. PubMed ID: 19164221
[No Abstract] [Full Text] [Related]
19. Chronic myeloid leukemia after treatment with 131 for thyroid carcinoma.
Wang KL; Lin LY; Chen PM; Lin HD
J Chin Med Assoc; 2005 May; 68(5):230-3. PubMed ID: 15909729
[TBL] [Abstract][Full Text] [Related]
20. Is radioiodine ablation necessary for patients with low-risk papillary thyroid carcinoma and tumor >4 cm?
Rosario PW
Eur J Surg Oncol; 2017 Sep; 43(9):1802-1803. PubMed ID: 28743373
[No Abstract] [Full Text] [Related]
[Next] [New Search]
